7
|
Igarashi M, Osuga JI, Uozaki H, Sekiya M, Nagashima S, Takahashi M, Takase S, Takanashi M, Li Y, Ohta K, Kumagai M, Nishi M, Hosokawa M, Fledelius C, Jacobsen P, Yagyu H, Fukayama M, Nagai R, Kadowaki T, Ohashi K, Ishibashi S. The Critical Role of Neutral Cholesterol Ester Hydrolase 1 in Cholesterol Removal From Human Macrophages. Circ Res 2010; 107:1387-95. [DOI: 10.1161/circresaha.110.226613] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Masaki Igarashi
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Jun-ichi Osuga
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Hiroshi Uozaki
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Motohiro Sekiya
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Shuichi Nagashima
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Manabu Takahashi
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Satoru Takase
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Mikio Takanashi
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Yongxue Li
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Keisuke Ohta
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Masayoshi Kumagai
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Makiko Nishi
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Masakiyo Hosokawa
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Christian Fledelius
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Poul Jacobsen
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Hiroaki Yagyu
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Masashi Fukayama
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Ryozo Nagai
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Takashi Kadowaki
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Ken Ohashi
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| | - Shun Ishibashi
- From the Departments of Metabolic Diseases (M.I., M.S., S.T., M. Takanashi, Y.L., K. Ohta, M.K., M.N., T.K., K. Ohashi), Pathology (H.U., M.F.), and Cardiovascular Medicine (R.N.), Graduate School of Medicine, University of Tokyo, Japan; Division of Endocrinology and Metabolism (J.-i.O., S.N., M.T., H.Y., S.I.), the Department of Medicine, Jichi Medical University, Tochigi, Japan; Faculty of Pharmaceutical Sciences, Chiba Institute of Science (M.H.), Japan; and Diabetes Research Unit (C.F., P.J.),
| |
Collapse
|
10
|
Jones C, Garuti R, Michaely P, Li WP, Maeda N, Cohen JC, Herz J, Hobbs HH. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest 2007; 117:165-74. [PMID: 17200716 PMCID: PMC1716209 DOI: 10.1172/jci29415] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2006] [Accepted: 10/10/2006] [Indexed: 11/17/2022] Open
Abstract
Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr(-/-)) and ARH (Arh(-/-)). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh(-/-) mice compared with Ldlr(-/-) mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh(-/-) mice than in Ldlr(-/-) mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh(-/-) mice (but not Ldlr(-/-) mice) internalized beta-migrating VLDL (beta-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.
Collapse
Affiliation(s)
- Christopher Jones
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Rita Garuti
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Peter Michaely
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Wei-Ping Li
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Nobuyo Maeda
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Jonathan C. Cohen
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Joachim Herz
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Helen H. Hobbs
- Department of Molecular Genetics and
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Center for Human Nutrition and
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| |
Collapse
|